[Editors' Choice] Channeling brain cancer
Drug development based on the antipsychotic drug thioridazine may lead to treatments for metastatic medulloblastoma without compromising quality of life.
Source: Signal Transduction Knowledge Environment - Category: Science Authors: Nancy Gough (mailto:ngough at aaas.org) Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Environmental Health | Medulloblastoma | Neurology | Science